ABSTRACT Impairment of left ventricular function is the major predictor of mortality after acute myocardial infarction, but it is not known whether this is best described by ejection fraction or by endsystolic or end-diastolic volume. We measured volumes, ejection fractions, and severity of coronary arterial occlusions and stenoses in 605 male patients under 60 years of age at 1 to 2 months after a first (n = 443) or recurrent (n = 162) myocardial infarction and followed these patients for a mean of 78 months for survivors (range 15 to 165 months). There were 101 cardiac deaths, 71 (70%) of which were sudden (instantaneous or found dead). Multivariate analysis with log rank testing and the Cox proportional hazards model showed that end-systolic volume (X2 = 82.9) had greater predictive value for survival than end-diastolic volume (X2 = 59.0) or ejection fraction (X2 = 46.6), whereas stepwise analysis showed that once the relationship between survival and end-systolic volume had been fitted, there was no additional significant predictive information in either end-diastolic volume or ejection fraction. Severity of coronary occlusions and stenoses showed additional prediction of only borderline significance (p = .04 in one analysis), but continued cigarette smoking did remain an independent risk factor after stepwise analysis. For a subset of patients (n = 200) who had taken part in a randomized trial of coronary artery surgery after recovery from infarction, surgical "intention to treat" showed no predictive value. We conclude that for prediction, end-systolic volume is the primary predictor of survival after myocardial infarction, being superior to ejection fraction when ejection fraction is low (<50%) or when end-systolic volume is high (< 100 ml). Treatment of infarction should be aimed at limitation of infarct size and prevention of ventricular dilation.
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Circulation 76, No. 1, 44-51, 1987. IT IS NOW RECOGNIZED that the major predictor of long-term survival after recovery from acute myocardial infarction is the functional status of the left ventricle. Left ventricular function has usually been described in terms of the ejection fraction (EF),1-4 but it is not clear whether EF is the most meaningful index of left ventricular function in the postinfarction situation. Low EF may, on the one hand, be caused by poor contractile function due to extensive myocardial damage or continuing ischemia or, on the other hand, to left ventricular dilation caused by infarct expansion and stretching of the myocardial scar. Thus end-systolic volume (ESV) or end-diastolic volume (EDV) might be more meaningful predictors of prognosis than EF, which is merely an arithmetical term based on these two values. In this study we used the Cox proportional hazards model to compare the individual predictive powers of ESV, EDV, and EF, together with other possible angiographic and clinical predictors of cardiac mortality in 605 patients. ESV was found to be the best predictor of prognosis, and standardization of the results for ESV showed that the severity of arterial lesions gave only weak and inconsistent additional predictive power.
Patients and methods
The study group consisted of 605 male patients under 60 years of age who had been investigated at 4 to 8 weeks after recovery from a first (n = 443) or recurrent (n = 162) myocardial infarction. First-infarction patients comprised 83% of consecutive hospital survivors who had been admitted to one coronary care unit between January 1977 and July 1984; patients with recurrent infarction comprised 78% of a combined population of patients from our own coronary care unit (66%) and referred patients (34%) who had been investigated between 1972 and 1979. The mean age of the patients was 50 ± 7 years (range 21 to 60). Reasons for exclusion of patients were the presence of other life-threatening disease, patient refusal to join the study, or death between discharge from hospital and planned readmission for investigation. Both series of patients have been the subject of previous reports, which described the anatomic and functional determinants of long-term prognosis after first infarction5 and the effect of coronary artery surgery on survival in relatively asymptomatic patients after recurrent infarction.6 Informed consent was obtained as described previously.6 Clinically important information presented here that was not in the previous studies relates to ESV and EDV, together with increased numbers of patients and a longer follow-up.
Myocardial infarction was diagnosed when at least two of the following abnormalities were present: (1) characteristic clinical presentation, (2) development of pathologic Q waves or evolutionary ST and T wave changes on the electrocardiogram, (3) an increase in creatine kinase above normal levels. Cardiac catheterization was carried out at 4 to 8 weeks after infarction. Selective coronary arteriography was performed by the Judkins technique and arteries were viewed in multiple projections. Left ventriculography was performed in the right anterior oblique position. Ventricular volumes and ejection fraction were calculated by an integration method with correction factors based on a comparison between true and calculated volumes of radiopaque left ventricular casts made from hearts at autopsy.] Normal values for our laboratory were obtained from analysis of left ventriculograms from 53 male patients under 60 years old (mean 41 ± 10) without coronary or valvular disease: EDV 132 ± 36 ml, ESV 39 ± 15 ml, and EF 71 ± 7%. Ventricular volumes were not indexed to body surface area in this study because there is lack of evidence for a relationship between ventricular volumes and body surface area in normal adult subjects,8 and this lack of relationship was confirmed by examination of the data from our own normal subjects. In 33 subjects in whom data on height and weight were available, the correlation between ESV and body surface area was r = .37 (r2 = .14; p <.05), implying that only 14% of the variation in ESV was accounted for by variation in body surface area. Coronary arteriographic findings were documented by our reporting system,9 which calculates myocardial score based not only on the severity of the arterial stenoses but also on the amount of left ventricular myocardium supplied by each involved vessel. As before,5 we divided the myocardial score into an "occlusion score," which was the percentage of left ventricular myocardium judged to have been supplied by occluded vessels, and a "stenosis score," which was the percentage of left ventricular myocardium supplied by arteries showing hemodynamically significant but incompletely obstructive lesions (75% to 99% cross-sectional area stenoses). Both the occlusion and stenosis scores were expressed as percentages of the total left ventricular myocardium, whereas the myocardial score was expressed as a number from 0 to 15. Less than 5 approximates one-vessel disease, 5 to 10 two-vessel disease, greater than 10 three-vessel disease.
After cardiac catheterization, all cases were discussed at a weekly combined cardiology and cardiac surgery conference. Surgery was offered for (1) all patients with left main coronary stenosis greater than 75% cross-sectional area, (2) Follow-up. Patients were seen every 6 to 12 months at our clinic and the clinical data were recorded. /8-Adrenoceptor blocking agents were prescribed for angina or hypertension but were not recommended for all patients. Weight reduction was recommended for the obese, but specific low-fat diets were usually not advised. Patients were strongly advised to stop smoking, and smoking habits and cardiac medication were recorded at each visit. Regular exercise was also recommended. If patients developed severe angina, despite medical therapy, cardiac catheterization was repeated and the need for surgery was reassessed. For patients who died, mode and circumstances of death were established from hospital notes or, for the majority of patients who died outside the hospital, from the patient's general practitioner or the next of kin. Deaths were classified as (1) sudden (instantaneous) if they occurred in the presence of witnesses with or without confirmation of terminal arrhythmia or if the patient was found dead having previously appeared to be in normal health; (2) deaths occurring within 30 days of recurrence of prolonged chest pain with or without confirmation of reinfarction; (3) deaths resulting from progressive cardiac failure; (4) deaths after cardiac surgery; or (5) deaths from noncardiac causes.
At the time of review (October 1985), only three of the 605 patients had been lost to follow-up; the mean follow-up period for survivors was 78 + 32 months (range 15 to 165).
Analysis of data. As before,5 data were stored on a PDP 11 computer. Differences between means were compared by use of the unpaired t test. Univariate analysis of cardiac mortality in relation to the catheter findings was performed by the KaplanMeier actuarial method, with analysis of differences between curves by the Mantel-Haenszel method. Correlations between EF and ESV were calculated by linear regression, and the slopes of the regression lines for survivors and cardiac deaths were compared. "
In addition, a full multivariate analysis of factors affecting the survival time was carried out with log rank testing and the Cox proportional hazards (multiple) regression model.'2 Factors subjected to multivariate analysis were EF, ESV, EDV, myocardial score, occlusion score, stenosis score, patient age, status of index infarction (first or recurrent), cardiac surgery, continued cigarette smoking, and treatment with ,8-blockers. To allay fears that the apparent effects of other prognostic variables had been created artificially by association with a surgical group, a stratified analysis also was performed on the levels of surgery. These levels were surgery as part of the randomized trial, early elective surgery (within 1 year of infarction), or late elective surgery (after 1 year). Data were analyzed both with respect to total cardiac mortality and to the occurrence of sudden cardiac death as defined above. A second Cox analysis was performed on the 200 patients who had entered the randomized surgical trials, including surgical "intention to treat" as a predictor, regardless of whether or not the patient had actually had surgery. Finally, the log relative risk = /1 (X -X0) + 032 (X2 -X02) was calculated where X was the value for ESV, XO was the normal ESV for our laboratory (39 ml), and ,/3 and /2 were the coefficients derived from the proportional hazards model.
Results
Cardiac surgery. Of the 200 patients who entered the randomized trials of coronary artery surgery, 100 (50 after first infarction and 50 after recurrent infarction) were randomly allocated to surgical management. Of these, 89 (49 patients after recurrent infarction6 and 40 after first infarction5) actually had surgery; the reasons for nonperformance of surgery were patient refusal, 
YERRS FIGURE 1. Actuarial survival curves constructed by dividing the patients into three groups according to their ESVs (top) or EFs (bottom).
Although both methods of classification give highly significant prediction for cardiac mortality (p <.001), the separation is wider with classification by ESV than with classification by EF. Numbers after the last data points shown numbers of patients at risk during the last year of follow-up.
than EDV (X2 = 59.0) or EF (x2 = 46.6). This is shown in figure 1 , in which separation of survival curves with stratification by ESV is greater than the separation with stratification by EF, and in figure 2, which shows that for patients with EF under 50% survival was significantly worse when ESV was above the median value for that group than it was when ESV was below the median value. Five year survival for these groups of patients, with 95% confidence limits, is shown in figure 5 . A full correlation matrix of the noncategorical variables that were entered into the Cox analysis is given in the appendix.
Discussion
Results of four other studies of prognosis in consecutive series of angiocardiographically defined patients after myocardial infarction'4 are compared with those of the present study in table 5. All five studies were performed on relatively young patients (mean age 49 to 51 years), and four of the five studies have shown so 100 150 200 SYSTOLIC VOLUME (ml) FIGURE 3 . Estimated relationships between ESV and relative risk of cardiac death over the follow-up period. The risk is relative to that of an individual with an ESV of 39 ml (normal for our laboratory). The risk does not rise steeply until ESV is 3 to 4 SD above normal. Fine lines indicate 95% confidence limits of relative risk. Strictly speaking, this curve applies only to nonsmokers (see text for details). a low cardiac mortality rate with only one cardiac death for every 456 to 500 patient-months of followup. This implies an overall cardiac mortality rate of just under 3% per year. As reported previously,5 6 3 did not use multivariate analysis; in the present study the coronary arterial lesions were more severe (although not markedly so) in patients who died than in those who survived, but the difference almost disappeared on multivariate analysis. Second, we believe that our scoring system,9 which takes into account not only the severity of the coronary lesions but also the amount of myocardium that these arteries supply, gives a more accurate picture of the overall severity of arterial disease than the terms one-, two-, or threevessel disease, which were used in the other studies. Third, the present study is larger, has a longer followup, and includes more than five times as many deaths as any of the previous studies, giving it much greater statistical power.
The fourth possibility for the lack of predictive value from the severity of arterial lesions in our study is that CIRCULATION FIGURE 4 . Relationship between EF and ESV for surviving patients (left) and patients dying of a cardiac cause (right). Correlations are simiilar (r = -.78) for both groups of patients, but for patients who died the slope of the relationship is significantly steeper than for those who survived (t -4.6, p <.001). in systolic and diastolic stress would lead to regional hypertrophy or remodeling. '9 As an index of left ventricular function, ESV is independent of preload but very dependent on afterload20 so that the absence of data on afterload at the time that ESV was measured is a limiting factor to our study. Despite these limitations, ESV was the most significant predictive factor of prognosis in our study, and the Cox analysis showed no additional information from either EF or EDV. When EF and ESV were compared in individual patients, addition of ESV clearly added prognostic power to stratification of mortality risk by EF alone (figure 2). Most of the cardiac deaths (70%) were sudden, implicating ventricular fibrillation as the mechanism. Presumably increased wall stress leading to increased myocardial oxygen demand is a risk factor for ventricular fibrillation because of reentry of electrical impulses between normal myocardium and fibers in the stretched ischemic scar. It is of interest that the severity of stenoses was not a risk factor in this study, implying that coronary thrombosis, if it preceded late sudden death,21 could not have been predicted from the presence of stenotic lesions after recovery from the index infarct.
It is possible that other known risk factors, not assessed in this study, might have added extra prognostic information to the ESV measurements. Ventricular arrhythmias detected during 24 hr Holter monitoring constitute a risk factor that is probably additive to the severity of left ventricular dysfunction.22 Ongoing reversible myocardial ischemia is another risk factor.23
In our study, patients with severe ongoing symptoms despite medical therapy were managed surgically. No attempts were made to evaluate asymptomatic ischemia, and it is possible that some deaths might have been related to jeopardized myocardium not identified by symptoms. Again it is possible that classification of coronary stenoses on the basis of their eccentricity and irregularity24 might give better prediction of future coronary thrombosis and cardiac death than classification in terms of cross-sectional area loss, which was used in the present and previous studies. Continued cigarette smoking has been identified in the past as a cause of increased cardiac mortality after recovery from infarction, [25] [26] [27] [28] and our results confirm that it is an independent risk factor. Apart from smoking, primary risk factors are probably not important predictors of prognosis once serious myocardial damage has occurred, although it is possible that imbalance between humoral procoagulant and anticoagulant factors29 might be additional risk factors for recurrent coronary thrombosis and cardiac death.
Identification of cardiac dilation as the major risk factor after myocardial infarction raises the question of how dilation might be prevented. Limitation of myocardial infarct size by reperfusion with an intravenous thrombolytic agent30 would seem the best strategy at present. In addition, Pfeffer et al. 3 ' have shown in rats with myocardial infarction and cardiac failure that reduction of left ventricular filling pressures with captopril prevents ventricular dilation and increases survival. It appears that studies involving alterations in blood pressure, heart rate, and contractility during the days and weeks after myocardial infarction in man are needed to assess the effects of interventions on the littleinvestigated healing phase of myocardial infarction. This includes the processes of infarct expansion, left ventricular dilation, and ventricular remodeling. 
